PLUS THERAPEUTICS, INC. reports

Company location: Austin, TX
Fiscal year end: 31 December

PLUS THERAPEUTICS, INC. has filed 1,439 SEC EDGAR filings since 30 Mar 2001

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page

25

Current page

38

4

FORM 4

Filing date: 04 Jan 2012
Reporting date: 01 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2012
Reporting date: 01 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2012
Reporting date: 01 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2012
Reporting date: 01 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2012
Reporting date: 01 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Jan 2012
Reporting date: 01 Jan 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Dec 2011
Reporting date: 14 Dec 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 14 Dec 2011
Reporting date: 08 Dec 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Dec 2011
Reporting date: 13 Dec 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 08 Dec 2011
Reporting date: 08 Dec 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 28 Nov 2011
Reporting date: 25 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Nov 2011
Reporting date: 17 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Nov 2011
Reporting date: 16 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Nov 2011
Reporting date: 15 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-34375

CYTORI THERAPEUTICS INC 10-Q 9-30-2011

Filing date: 08 Nov 2011
Reporting date: 30 Sep 2011
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 11-3-2011

Filing date: 03 Nov 2011
Reporting date: 03 Nov 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 9-9-2011

Filing date: 15 Sep 2011
Reporting date: 09 Sep 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Sep 2011
Reporting date: 14 Sep 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Sep 2011
Reporting date: 14 Sep 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Sep 2011
Reporting date: 14 Sep 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Aug 2011
Reporting date: 19 Aug 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Aug 2011
Reporting date: 19 Aug 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Aug 2011
Reporting date: 22 Aug 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 8-19-2011

Filing date: 19 Aug 2011
Reporting date: 16 Aug 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Aug 2011
Reporting date: 12 Aug 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .